Filing Details

Accession Number:
0001181431-11-025300
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-25 20:07:37
Reporting Period:
2011-04-20
Filing Date:
2011-04-25
Accepted Time:
2011-04-25 20:07:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369786 Sagent Holding Co. SGNT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227255 Frank Kung C/O Sagent Pharmaceuticals, Inc.
1901 North Roselle Road, Suite 700
Schaumburg IL 60195
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-20 20,000 $16.00 26,379 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,961,452 Indirect See Footnote
Footnotes
  1. The shares reported are held of record collectively by Vivo Ventures Fund V, L.P., Vivo Ventures V Affiliates Fund, L.P., Vivo Ventures Fund VI, L.P. and Vivo Ventures VI Affiliates Fund, L.P. (the "Vivo Funds"). Dr. Kung is the managing partner of Vivo Ventures. As a result, Dr. Kung may be deemed the beneficial owner of the shares of common stock owned collectively by the Vivo Funds. Dr. Kung hereby disclaims any beneficial ownership of any shares directly held by the Vivo Funds, except to the extent of his pecuniary interest therein.